CNSP icon

CNS Pharmaceuticals

10 hedge funds and large institutions have $228K invested in CNS Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 6 reducing their positions, and 12 closing their positions.

Holders
10
Holders Change
-9
Holders Change %
-47.37%
% of All Funds
0.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
6
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
AFM
1
Anson Funds Management
Texas
$223K 141,398 +141,398 New
UBS Group
2
UBS Group
Switzerland
$4.15K 2,629 +2,629 New
TRCT
3
Tower Research Capital (TRC)
New York
$182 115 -6,657 -98%
Wells Fargo
4
Wells Fargo
California
$6 4 -237 -98%
Morgan Stanley
5
Morgan Stanley
New York
$3 2 -65 -97%
GRP
6
Global Retirement Partners
California
$3 2 -51 -96%
Bank of America
7
Bank of America
North Carolina
$2 1 -778 -100%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$2 1 -13 -93%
PMFA
9
Plante Moran Financial Advisors
Michigan
$2 1
PA
10
Parallel Advisors
California
$2 1 +1 New
AC
11
Armistice Capital
New York
-471,000 Closed
VF
12
Virtu Financial
New York
-94,246 Closed
Citadel Advisors
13
Citadel Advisors
Florida
-91,034 Closed
SAF
14
Smith Anglin Financial
Texas
-90,332 Closed
Vanguard Group
15
Vanguard Group
Pennsylvania
-58,369 Closed
Geode Capital Management
16
Geode Capital Management
Massachusetts
-28,254 Closed
Jane Street
17
Jane Street
New York
-27,388 Closed
State Street
18
State Street
Massachusetts
-22,556 Closed
HF
19
HRT Financial
New York
-21,898 Closed
TSS
20
Two Sigma Securities
New York
-21,806 Closed
FWA
21
FSM Wealth Advisors
Ohio
-19,084 Closed
XT
22
XTX Topco
Cayman Islands
-18,729 Closed
CFGS
23
Concourse Financial Group Securities
Alabama